Answers are grounded in this paper and cite their sources.
The findings indicate that LATS globulin is not the product of a monoclonal selection process and confirm its immunoglobulin nature.
Tests were made of the ability of specific antisera against kappa- and lambda-type B chains of human immunoglobulin to inactivate the biologic activity of 7 different sera containing long-acting thyroid stimulator (LATS) globulin. In each instance serum LATS activity was inactivated partly by anti-kappa and partly by anti-lambda/antiserum, and the combined inactivation by both antisera approximated 100%. The findings are interpreted as showing that LATS globulin is not the product of a cell line derived by a monoclonal selection process. In addition, the results add further evidence confirming the immunoglobulin nature of LATS.
No takes yet. Share an insight, caveat, or question.
Joseph P. Kriss (1968) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: